Gliomas

Gliomas are tumors that begin in glial cells, which support nerve cells in the brain or spinal cord. Some gliomas grow slowly, while others are aggressive and may grow or spread more quickly. Gliomas can affect children or adults, and their effects depend partly on where they develop. The term glioma includes several different tumor types and grades.

Gliomas develop when glial cells acquire genetic changes that disrupt normal growth and allow the cells to multiply without control. These changes may build up during a person’s lifetime or, less commonly, be related to an inherited condition. In most cases, doctors cannot identify one specific cause of a glioma tumor.

Inherited and acquired genetic changes

Most genetic changes linked with glioma are acquired in the tumor cells rather than passed from a parent. Rare inherited syndromes can increase risk, and prior therapeutic radiation to the head is another uncommon association. Gliomas are not generally caused by lifestyle choices; ordinary cell phone use, stress, or diet are not established causes.

Complications depend on the tumor’s location, size, grade, growth pattern, and treatment. A low grade glioma may cause problems gradually, while a high grade glioma may cause more rapid changes. Rehabilitation, symptom management, and supportive services may help preserve function and quality of life.

Evaluation usually begins with a neurologic examination to check strength, sensation, coordination, vision, speech, memory, and other brain functions. Magnetic resonance imaging (MRI) is commonly used to locate a suspected glioma and assess its size and effects. Computed tomography (CT) or other imaging may be used when appropriate.

Biopsy and tumor testing

A biopsy or tissue obtained during surgery may be examined in a laboratory to identify the tumor type and grade. Testing can also look for genetic alterations and molecular markers that help guide treatment. Gliomas are generally graded by how abnormal and fast-growing the cells appear rather than described only by conventional cancer stages. Low grade gliomas tend to look less abnormal and grow more slowly, while high grade gliomas tend to be more aggressive. A grade 4 glioma is not automatically synonymous with glioblastoma, because the exact tumor type and molecular findings also matter.

Surgery or tumor resection

Surgery may be considered to remove as much tumor as can be safely removed, relieve pressure, or obtain tissue for diagnosis. Surgeons use imaging and neurologic monitoring to protect important brain functions. Recovery varies by tumor location and the procedure; temporary or lasting weakness, speech changes, seizures, or other neurologic effects are possible.

Radiation therapy

Radiation uses focused energy to damage tumor cells and may be recommended after surgery, for tumors that cannot be safely removed, or for recurrent or high grade glioma. It is delivered in planned treatment sessions, and short-term effects may include tiredness, scalp irritation, nausea, or worsening symptoms from swelling. Follow-up visits and imaging help assess response and manage late effects.

Drug therapy

Chemotherapy, targeted therapy, or other tumor-specific medicines may be selected according to the tumor’s type, grade, molecular features, and prior treatment. Monitoring may include blood tests, imaging, and checks for effects such as fatigue, nausea, infection risk, or other medicine-specific problems. Treatment plans may combine medicines with surgery or radiation. Clinical trials may provide additional options, while seizure control, rehabilitation, palliative care, and support services can address symptoms, function, comfort, and quality of life.

Glioma outlook depends on age, overall health, tumor location and size, grade, molecular features, how much tumor can be safely removed, response to treatment, and whether the tumor returns. Low grade gliomas are generally slower growing, while high grade gliomas are usually more aggressive and may require intensive treatment. These differences explain why a glioma survival rate cannot be applied equally to every person, including someone with stage 4 glioma.

Follow-up commonly includes scheduled neurologic visits and repeat MRI scans. The timing is adjusted to the tumor type, grade, treatment, symptoms, and risk of recurrence or progression. The care team may change the schedule if new symptoms appear or if scans show a change.

Long-term support and recovery